In-Vitro Colorectal Cancer Screening Test Market worth US$ 2.5 Billion at a CAGR of 7.1% by 2034 - Transparency Market Research

News provided by

Jul 22, 2024, 12:36 ET

The disease that damages the rectum or colon is called colorectal cancer, which is the largest cancer type that affects a large number of patients, and has the highest mortality rate. With the help of elevated screening in many countries, however, this number is successfully reduced, elevating the life expectancy.

WILMINGTON, Del., July 22, 2024 /PRNewswire/ -- Owing to several contributing factors, the in-vitro colorectal cancer screening test market is expected to attain a USD 2.5 billion valuation mark by 2034. The industry was measured at USD 1.2 billion in 2023.

The progress of the competitive landscape is estimated to encompass a decent advancement through the forecasted period. With the scope of advancement adhering to a moderate CAGR of 7.1%, the industry avails better opportunities to key players in the sector.

Owing to the changing lifestyles, consumers are found to be inclined toward several ill habits. Ranging from bad food habits like overeating processed food to excessive drinking and smoking, such lifestyle changes are an opportunity for serious diseases like cancer.

Download Sample PDF Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3698

Pertaining to the growing cases of obesity, people have become more prone to such illnesses, which drives the demand for effective diagnosis and treatment. As a result, this is a key driver for the industry, which elevates the size of the sector.

The growing prevalence of cancer cases is a key opportunity for many therapies and treatments. Along with this, effective diagnosis is being demanded by consumers as well as medical professionals. This drives the demand for in-vitro colorectal cancer screening test kits.

Colorectal cancer comprises almost 10% of the total cancer cases, which drives the demand for in-vitro colorectal cancer screening test kits. Due to the higher mortality rate of this cancer, people have become more aware of the disease.

The growing awareness of cancer and treatments for the disease leverages more space for test kits in the industry, fueling growth prospects for key players. As a result, leading organizations can expand better in the industry.

The growing investments in the healthcare sector are another determinant of a spike in the demand for test kits. Due to better infrastructure, more prospects are created for leading players in the industry, fueling market growth.

The development of large hospitals and other medical facilities has given better choices to patients for effective diagnosis and treatment. Albeit the cancer is usually detected in later stages, with cutting-edge facilities, treatments can be simplified, benefitting patients.

In-vitro Colorectal Cancer Screening Tests Market Report Scope:

Report Coverage	Details
Forecast Period	2024-2034
Base Year	2020-2022
Size in 2023	US$ 1.2 Bn
Forecast (Value) in 2034	US$ 2.5 Bn
Growth Rate (CAGR)	7.1 %
No. of Pages	120 Pages
Segments covered	By Test Type, By End-user, By Region

Key Findings from the Market Report

In the vast competitive landscape, the global in-vitro colorectal cancer screening test market can be segmented into different verticals. Based on the type of the test, the fecal immunochemical test (FIT) segment is likely to gain more demand due to the effectiveness of tests in symptomatic patients.
Fecal DNA tests form another key category, which can check mutations of cells in stool to yield better results. This segment, thus, will gain traction in the forecasted period.
With the growing investments in the healthcare sector, diagnostic centers are growing. The segment is expected to gain popularity in the future.
Based on the end-user segment, hospitals and clinics are expected to fuel the growth of the industry. Due to the cutting-edge facilities, hospitals can provide better assistance to patients, driving the demand for the segment of the sector.

Regional Profile

The growing number of cancer patients in Europe will create lucrative prospects for leading organizations in the in-vitro colorectal cancer screening test market.
The robust healthcare infrastructure in North America drives the market with more force.
The growing investments in the healthcare industry in Asia-Pacific will elevate the size of the industry in the region.

Request Table of Content Here: https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=3698

Competitive Landscape
Product launch is a key mode of expansion adopted by leading players in the in-vitro colorectal cancer screening test market.

Abbott Laboratories is a key player that has acquired a wide range of brands and produces various cardiovascular, nutritional, and diagnostics products.
Thermofisher Scientific Inc. produces beakers and lids, funnels, biochemical reagents, and many more.
Eiken Chemical Co., Ltd. is another organization producing fecal testing OC-SENSOR, culture media, veterinary VET-SAA Eiken, and many more.

Key Developments in the In-vitro Colorectal Cancer Screening Test Market

In January 2024, Abbott Laboratories launched a new Protality brand, which aims to help people lose weight.
In June 2024, Thermofisher Scientific Inc. introduced an innovative mass spectrometer, aiming to help advanced clinical research.

Key Players

Abbott Laboratories
Thermofisher Scientific Inc.
Eiken Chemical Co. Ltd
Qiagen
Quest Diagnostics Incorporated
Sentinel CH. S.p.A
Quidel Corporation
Freenome Holdings Inc.
Immunostics Inc.
BTNX Inc.
Other Prominent Players

Market Segmentation
Test Type

Fecal DNA Test Kits
Fecal immunochemical test (FIT)
Guaiac Fecal Occult Blood Test (gFOBT) Kits
Others

End User

Hospitals & Clinics
Diagnostic Centers
Others

Region

North America
Latin America
Europe
Asia Pacific
Middle East & Africa

Purchase the Report for Market-Driven Insights: https://www.transparencymarketresearch.com/checkout.php?rep_id=3698&ltype=S

Have a Look at More Valuable Insights of Consumer Goods

Aesthetic Implants Market: The global aesthetic implants market is projected to flourish at a CAGR of 5.6% from 2022 to 2031. As per the report published by TMR, a valuation of US$ 8.4 billion is anticipated for the market in 2031. As of 2023, the market for aesthetic implants is expected to close at US$ 5.3 billion.
Dental Apex Locator Market: The last recorded market valuation of the global dental apex locator market was about US$ 73.9 million in 2021. This market valuation is projected to grow to US$ 140.1 million by the end of 2031. This forecasted market advancement shall be at a CAGR of 6.6%.
Onco-hematology Molecular Testing Market: Increase in incidence of blood cancers, rise in awareness about early diagnosis, advancements in testing technologies, and development of targeted therapies are driving the global onco-hematology molecular testing market.
Lung Cancer Diagnostics Market: Increase in incidence of lung cancer, especially in developing countries, is the key driver of the global lung cancer diagnostics market. Surge in awareness about the importance of early and accurate diagnosis of the cancer is expected to accelerate industry development.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: [email protected]
Follow Us: LinkedIn| Twitter| Blog | YouTube